These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 140398)

  • 1. Interaction of perphenazine and an ergoline derivative on oestrogen-induced adenohypophyseal growth.
    Schreiber V; Pribyl T
    Physiol Bohemoslov; 1977; 26(1):31-8. PubMed ID: 140398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition by an ergoline derivative (dopaminergic agonist) of oestradiol-induced adenohypophyseal growth and of the decrease in the hypothalamic ascorbic acid (HAA) concentration in rats.
    Schreiber V; Pribyl T; Jahodová J
    Physiol Bohemoslov; 1982; 31(2):97-100. PubMed ID: 6212960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the oestradiol-induced increase in adenohypophyseal weight and in hypothalamic and serum polyphenol oxidase activity by dopaminergic agonists.
    Schreiber V; Pribyl T; Jahodová J
    Physiol Bohemoslov; 1983; 32(2):117-20. PubMed ID: 6408657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactions of hypothalamic ascorbic acid, serum ceruloplasmin and the adenohypophysis to oestradiol: inhibition by L-thyroxine.
    Schreiber V; Pribyl T; Jahodová J
    Physiol Bohemoslov; 1980; 29(1):11-20. PubMed ID: 6444734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic antagonists potentiate the adenohypophyseal growth reaction to oestrogen: thioridazine is less effective than perphenazine.
    Schreiber V; Pribyl T; Jahodová J
    Physiol Bohemoslov; 1987; 36(1):9-13. PubMed ID: 2884683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic modulation of the adenohypophyseal reaction to oestradiol: interaction of perphenazine with the thyroid hormones.
    Schreiber V; Pribyl T; Jahodová J
    Physiol Bohemoslov; 1980; 29(2):173-9. PubMed ID: 6446099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of thyroxine binding to adenohypophysial proteins in vitro by 2,4-dinitrophenol administered in vivo.
    Schreiber V; Pribyl T; Jahodová J
    Physiol Bohemoslov; 1975; 24(2):147-56. PubMed ID: 124882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic control of adenohypophyseal growth.
    Schreiber V
    Vopr Biokhim Mozga; 1978; 13():221-7. PubMed ID: 756643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleolar inhibition in prolactin cells after combined thyroid hormone plus lisuride treatment in estrogenized rats.
    Dusková J; Schreiber V
    Endocrinol Exp; 1989 Sep; 23(3):185-94. PubMed ID: 2572415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of interaction of oestrogen, testosterone and thyroid hormones on the serum ceruloplasmin level in rats.
    Schreiber V; Pribyl T
    Physiol Bohemoslov; 1977; (2):129-37. PubMed ID: 140385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metoclopramide potentiates the hypophyseal reactions to oestradiol.
    Schreiber V; Dusková J; Pribyl T; Svobodová V; Jahodová J
    Physiol Bohemoslov; 1984; 33(5):385-9. PubMed ID: 6505072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioestrogenic action of the aldosterone antagonist canrenoate K in the rat (adenohypophysis, ceruloplasmin).
    Schreiber V; Pribyl T
    Physiol Bohemoslov; 1977; 26(5):385-95. PubMed ID: 144921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial inhibition of oestrogen-induced adenohypophyseal growth by silver nitrate.
    Pribyl T; Jahodová J; Schreiber V
    Horm Res; 1980; 12(5):296-303. PubMed ID: 7399401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the growth reaction of the rat adenohypophysis to oestrogen by an ergoline derivative.
    Schreiber B; Pribýl T; Rohácová J
    Physiol Bohemoslov; 1973; 22(1):11-7. PubMed ID: 4269742
    [No Abstract]   [Full Text] [Related]  

  • 15. Modulation oestradiol effects by silver nitrate: inhibition of the adenohypophyseal reaction, block of the ceruloplasmin increase and block of hypothalamic ascorbic acid depletion.
    Schreiber V; Pribyl T; Jahodová J
    Endokrinologie; 1980 Oct; 76(2):129-36. PubMed ID: 7449747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of hexose monophosphate shunt inhibitors on adenohypophyseal and ceruloplasmin reactions to oestrogen.
    Schreiber V; Pribyl T
    Physiol Bohemoslov; 1978; 27(4):301-7. PubMed ID: 151286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic control of adenohypophyseal growth after oestrogens: negative results with L-DOPA, RO-4-4602, alpha-methyl-DOPA, apomorphine, haloperidol, pyridoxine and cyproheptadine.
    Schreiber V; Pribyl T; Jahodová J
    Physiol Bohemoslov; 1978; 27(4):308-12. PubMed ID: 151287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the effect of oestradiol on adenohypophyseal weight: ineffectiveness of nickel chloride, potentiation by cimetidine.
    Schreiber V; Pribyl T; Svobodová V; Jahodová J
    Physiol Bohemoslov; 1984; 33(1):11-6. PubMed ID: 6709725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin binding to mammary gland, 7,12-dimethylbenz(a)-anthracene-induced mammary tumors, and liver in rats.
    Smith RD; Hilf R; Senior AE
    Cancer Res; 1976 Oct; 36(10):3726-31. PubMed ID: 821605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restitution of endocrine changes after discontinuing chronic oestradiol administration in rats.
    Schreiber V; Pribyl T; Jahodová J
    Physiol Bohemoslov; 1978; 27(6):505-13. PubMed ID: 152926
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.